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To determine whether insulin action on endothelial
cells promotes or protects against atherosclerosis,
we generated apolipoprotein E null mice in which
the insulin receptor gene was intact or conditionally
deleted in vascular endothelial cells. Insulin sensi-
tivity, glucose tolerance, plasma lipids, and blood
pressure were not different between the two groups,
but atherosclerotic lesion size was more than 2-fold
higher in mice lacking endothelial insulin signaling.
Endothelium-dependent vasodilation was impaired
and endothelial cell VCAM-1 expression was in-
creased in these animals. Adhesion of mononuclear
cells to endothelium in vivo was increased 4-fold
compared with controls but reduced to below control
values by a VCAM-1-blocking antibody. These results
provide definitive evidence that loss of insulin
signaling in endothelium, in the absence of competing
systemic risk factors, accelerates atherosclerosis.
Therefore, improving insulin sensitivity in the endo-
thelium of patients with insulin resistance or type 2
diabetes may prevent cardiovascular complications.
INTRODUCTION
Insulin stimulates signal transduction in endothelial cells (Zeng
and Quon, 1996) and augments endothelial vasodilator function
(Steinberget al., 1994).Multiple studieshaveshown that systemic
insulin resistance is associated with impaired vascular insulin
signaling (Jianget al., 1999) andbluntedvascular effectsof insulin
(Steinberg et al., 1996). Insulin resistance (Howard et al., 1996)
and the resultant hyperinsulinemia (Despres et al., 1996) are inde-
pendent risk factors for vascular disease. These associations
could be due to excessive insulin action on endothelial cells
during hyperinsulinemia or decreased endothelial insulin action
due to vascular insulin resistance, but the relative roles of such
effects have been controversial (Rask-Madsen and King, 2007).CBoth antiatherosclerotic and proatherosclerotic mechanisms
activated by insulin have been described in vascular endothelial
cells. Antiatherogenic actions of insulin include increased
production of nitric oxide (NO) (Kuboki et al., 2000; Steinberg
et al., 1994; Zeng and Quon, 1996), decreased endothelial cell
apoptosis (Hermann et al., 2000), decreased production of reac-
tive oxygen species (Du et al., 2006), and increased expression
of genes with antioxidant effects, like heme oxygenase-1 (HO-1)
(Geraldes et al., 2008). Conversely, increased expression of
endothelin-1 (Cardillo et al., 1999; Oliver et al., 1991) and plas-
minogen activator inhibitor-1 (PAI-1) (Grenett et al., 1998; Nordt
et al., 1998) are among proatherogenic actions of insulin on
vascular endothelial cells. There have been reports of both
increased (Madonna et al., 2004; Okouchi et al., 2002) and
decreased (Aljada et al., 2000; Booth et al., 2001) expression
of adhesion molecules after insulin stimulation.
Despitemechanistic information about presumedanti- or proa-
therosclerotic effects of insulin signaling in endothelial cells, the
net effect of endothelial insulin action on the development of
atherosclerosis is unknown. In order to improve management of
the cardiovascular risk profile particular to patients with insulin
resistance or diabetes (Reusch and Draznin, 2007), it is critical
to understand the effects of insulin directly on endothelial cells
and the consequences of insulin resistance in endothelium.
Thus, if hyperinsulinemia is detrimental, intensive insulin treat-
ment could potentially have adverse effects in the vascular endo-
thelium, thereby blunting the effects of improved control of
glucose and lipid metabolism. Conversely, if the direct action of
insulin on the endothelium has an antiatherosclerotic effect, ther-
apies thatpreventor improve insulin resistance inendothelial cells
could decrease the risk of atherosclerosis. These local effects
may be different from the results of targeting insulin resistance
at the whole-body level. For example, we have previously shown
that treatmentwithan inhibitor specific for theb-isoformofprotein
kinase C normalized the severely compromised insulin-stimu-
lated NO production in the aorta of insulin resistant rats but had
no effect on whole-body insulin sensitivity (Naruse et al., 2006).
To determine whether the loss of insulin action on endothelial
cells, similar to what is observed in patients with insulin resis-
tance (Rask-Madsen et al., 2001; Steinberg et al., 1996),
promotes or retards atherosclerosis, we generated endothelialell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc. 379
Figure 1. Insulin Receptor Expression and
Insulin Signaling
(A–D) Insulin 5 mU/g i.v. was given to mice fasted
overnight and tissues collected after 5 min. Repre-
sentative western blots (top) show IRb protein
expression and insulin-stimulated Akt Ser473
phosphorylation in lysate of the tissues indicated;
also shown are mean values of IRb protein after
densitometry of western blots from three indepen-
dent experiments (bottom).
(E and F) Aorta was digested by collagenase, and
endothelial cells were isolated by immunoselec-
tion with magnetic microbeads complexed with
ICAM2 antibody, with aortic smooth muscle cells
grown from the ICAM2-negative fraction. Cultures
were treated with insulin (10 nM, 5 min) after 24 hr
of serum starvation. (E) Representative western
blots from whole-cell lysate of primary culture of
aortic endothelial cells are shown. (F) Mean values
of Akt Ser473 phosphorylation were based on
densitometry of western blots from three indepen-
dent experiments.
(G) Western blots from whole-cell lysate of aortic
smooth muscle cells representative of three inde-
pendent experiments.
(H and I) Insulin 10mU/g was given i.v. in wild-type
and Akt2–/– mice. After 5 min, the aorta was iso-
lated and snap frozen. (H) Representative western
blots of aorta lysate. (I) Mean values of Akt Ser473
phosphorylation based on data from 10 wild-type
and 13 Akt2–/– mice. See also Figure S1. Abbrevi-
ations: c, control mice; E, EIRAKOmice; WT, wild-
type mice.
In graphs, error bars represent standard error of
the mean.
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using the Cre/loxP system to achieve a conditional knockout of
the insulin receptor gene targeted to endothelial cells. These
animals were compared with littermate apolipoprotein E (apoE)
knockout mice with intact insulin receptor genes (‘‘controls’’).
Our results show that atherosclerotic disease progression is
more severe in EIRAKO mice compared with controls, despite
there being no differences in whole-body insulin sensitivity,
glucose tolerance, plasma lipids, or blood pressure between
the two groups. These results provide definitive evidence that
loss of insulin signaling in the endothelium, in the absence of
competing systemic risk factors, accelerates atherosclerosis.
RESULTS
Insulin Receptor Expression and Insulin Signaling
EIRAKO mice were bred as described in the Experimental
Procedures and maintained on regular chow with 22% of calo-380 Cell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc.ries provided by fat. A PCR product rep-
resenting Cre-mediated recombination
was amplifed from tail biopsies from
EIRAKO mice, but not from hair, which
contains no endothelial cells (see Fig-
ure S1A available online, see also
the Supplemental Experimental Proce-dures). In most organs, endothelial cells constitute only a small
fraction of the total cell number. Accordingly, insulin receptor-
b (IRb) protein expression and insulin-stimulated Akt Ser473
phosphorylation did not differ between control and EIRAKO
mice in skeletal muscle (Figure 1A), liver (Figure 1B), or adipose
tissue (Figure 1C). In lung tissue, IRb protein was decreased by
50% (Figure 1D), likely because of the high content of endothe-
lial cells in this tissue. Lung endothelial cells were isolated
using magnetic microbeads complexed to ICAM-2 antibody
during two sequential passages, which resulted in > 99%
CD31+ cells (Figure S1B). IRb protein was clearly expressed
in cultures from control mice but was not detectable in cultures
from EIRAKO mice (Figure S1C, limit of detection described
in the Supplemental Experimental Procedures). Insulin at a
concentration of 10 nM increased Akt Ser473 phosphorylation
more than 6-fold in lung endothelial cells from control animals
but had no effect in cells from EIRAKO mice (Figures S1C
and S1D).
Figure 2. Whole-Body Glucose Tolerance
and Insulin Sensitivity, Plasma Lipids, Blood
Pressure
(A) Blood glucose during glucose tolerance test.
(B) Plasma insulin during glucose tolerance test.
(C) Plasma glucose during insulin tolerance test.
(D–G) Plasma lipids were measured in 12 EIRAKO
mice and 11 littermate controls after a 4–6 hr fast.
Plasma fractions were obtained by FPLC in a
subset of three EIRAKO mice and three littermate
controls. (D) Total cholesterol in plasma. (E) Total
triglycerides in plasma. (F) Cholesterol concentra-
tion in FPLC fractions of plasma. (G) Triglyceride
concentration in FPLC fractions of plasma.
(H) Blood pressure was measured by tail vein
plethysmography in 14 EIRAKOmice and 12 litter-
mate controls. Mean values for systolic and dia-
stolic blood pressure (open triangles) as well as
mean blood pressure (closed circles) are shown.
In graphs, error bars represent standard error of
the mean.
Cell Metabolism
Endothelial Insulin Resistance and AtherosclerosisSince lung endothelial cells are mostly of microvascular
origin, we also examined macrovascular endothelial cells, iso-
lated with the same approach of immunomagnetic sorting as
described above. As with microvascular endothelial cells, no
IRb protein was detectable in cultured aortic endothelial cells
from EIRAKO mice (Figure 1E). Insulin had no effect on Akt
Ser473 phosphorylation in these cells, compared with a 4-fold
increase in Akt phosphorylation in cells from control animals
after insulin treatment (Figures 1E and 1F, p < 0.001). Similarly,
insulin treatment caused a 50% ± 18% increase in Erk1/2 phos-
phorylation in aortic endothelial cells from control mice but had
no effect on cells from EIRAKO mice (Figure 1E). Of note, unsti-
mulated Erk phosphorylation was increased by 71% ± 7% in
cells from EIRAKOmice compared with control cells (Figure 1E).
A similar increase in unstimulated Erk phosphorylation was
found in lung endothelial cells, where Erk phosphorylation in
cells from EIRAKO was 55% ± 20% higher than in cultures
from control animals (p = 0.03, data not shown). Insulin-like
growth factor-I receptor-b (IGF-IRb) protein was not differentCell Metabolism 11, 379in lung or aortic endothelial cells from
EIRAKO compared to control mice (Fig-
ure 1E). In cultures of aortic smooth
muscle cells, IRb protein and insulin-
stimulated Akt phosphorylation were
not different between the two groups of
mice (Figure 1G).
A recent publication showed that in
Akt1–/– mice, insulin-stimulated Akt phos-
phorylation was intact in whole lysate and
in Akt2 immunoprecipitates from vascular
tissue (Symons et al., 2009). We injected
insulin intravenously inAkt2–/– and control
mice and found that in the aorta, Akt
phosphorylation at Ser473 increased by
5.7- ± 1.0-fold in wild-type mice, but
only by 2.0- ± 0.4-fold in Akt2–/– mice
(Figures 1H and 1I, p = 0.003 for the
stimulated value in wild-type comparedto Akt2–/– mice). Therefore, a major part of vascular insulin
signaling is mediated by Akt2.
Metabolic Parameters and Blood Pressure
Body mass was not different between EIRAKO mice and their
littermate controls (37.3 ± 0.8 versus 37.3 ± 1.6 g at 24 weeks
of age, 43.9 ± 3.7 versus 42.7 ± 4.8 g at 52 weeks of age).
Furthermore, no difference was seen in random-fed blood
glucose (136 ± 8 and 134 ± 9 mg/dl at 12 weeks and 152 ± 24
and 149 ± 12 mg/dl at 52 weeks in EIRAKO and control mice,
respectively, p > 0.8) or fasting plasma glucose (data not shown).
Intraperitoneal glucose tolerance tests showed no difference in
blood glucose (Figure 2A) or plasma insulin (Figure 2B) between
EIRAKO and control mice, and intraperitoneal insulin tolerance
tests did not differ with respect to glucose levels between the
two groups (Figure 2C).
Total cholesterol and triglyceride concentrations in plasma
from animals fasted 4–6 hr were not different between EIRAKO
and control mice at 24 weeks of age (Figures 2D and 2E).–389, May 5, 2010 ª2010 Elsevier Inc. 381
Figure 3. Atherosclerotic Lesion Size in the Aorta
(A) Microphotographs of aortas from an EIRAKO mouse and its littermate
control at 24 weeks of age in the en face flat preparation after staining with
Sudan IV.
(B) Stained aortas at 52 weeks of age.
(C) Summary data from quantitation of atherosclerotic lesion area relative
to total area of the aorta in 10 EIRAKO mice and eight littermate controls at
24 weeks of age.
(D) Summary data from 9 EIRAKO animals and 11 littermate controls at
52 weeks of age.
In graphs, error bars represent standard error of the mean.
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significant differences in mice fasted overnight or mice fasted
4–6 hr or overnight at 12 weeks of age (data not shown). Choles-
terol and triglyceride concentrations were also measured in
lipoprotein fractions separated by fast protein liquid chromatog-
raphy (FPLC) and were similar between the two groups of
animals (Figures 2F and 2G).
Blood pressure and pulse were measured by tail vein plethys-
mography. There were no significant differences in systolic
blood pressure, diastolic blood pressure, or mean blood pres-
sure between the two groups (Figure 2H). Thus, the loss of insulin
receptors in the endothelium did not change whole-body
glucose tolerance, systemic insulin sensitivity, plasma lipids, or
blood pressure.
Atherosclerosis in the Aorta and Brachiocephalic Artery
Atherosclerotic lesions were evaluated in several different ways.
The entire aorta was stained with Sudan IV to visualize athero-
sclerotic plaques in flat preparations (en face preparations)
(Figures 3A and 3B). Atherosclerotic plaques were not observed382 Cell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc.in vascular endothelial insulin receptor knockout (VENIRKO)
mice (Vicent et al., 2003), which have no apoE gene mutation
(data not shown). In EIRAKO mice, the mean atherosclerotic
lesion area, expressed relative to total aortic luminal area,
was 2.1-fold greater at 24 weeks than in littermate controls
(3.5% ± 1.1% and 1.6% ± 0.4%, respectively, p = 0.01, Fig-
ure 3C) and 2.9-fold greater at 52 weeks (34.1% ± 4.1% and
11.8% ± 2.0%, respectively, p = 0.00007, Figure 3D). Lesion
area normalized to values for littermate controls was also ana-
lyzed. By this approach, when lesion area in each EIRAKO mice
belonging to a given litter was expressed as a fraction of the
average lesion area in control animals belonging to that litter,
results were similar (lesion area in EIRAKO mice 2.7 ± 0.5 times
higher than controls at 24 weeks, p = 0.02; 4.4 ± 1.6 times higher
than controls at 52 weeks, p = 0.02).
Atherosclerotic lesions were also analyzed in the brachioce-
phalic artery in mice 36 weeks of age by quantitatively extracting
lipids from the brachiochephalic artery with chloroform/meth-
anol followed by measurement of cholesteryl ester content by
mass spectroscopy. As cholesteryl ester is a major component
of the lipid accumulated in atherosclerotic plaques, this provided
a measure of plaque volume. Cholesteryl ester content in the
brachiocephalic artery was more than 2-fold higher in EIRAKO
mice compared to controls (9.6 ± 3.1 and 4.5 ± 0.7 nmole,
respectively, p = 0.03, Figure 4A) and more than 3-fold higher
at 52 weeks (25.7 ± 7.4 and 8.1 ± 1.4 nmole, respectively,
p = 0.048, Figure 4B). After lipid extraction, the brachiocephalic
arteries were analyzed histologically. Planimetry of the area
covered by plaques in histological cross-sections showed
that plaque area was larger in EIRAKO mice, although this
did not reach statistical significance (38,578 ± 11,245 and
17,091 ± 9,506 mm2 in EIRAKO mice and their controls, respec-
tively; p = 0.4; Figure 4C). Collagen, stained blue by Masson’s
trichrome, was distributed throughout plaques in both groups
(Figure 4C). There were significantly more vascular smooth
muscle cells per plaque cross-section in EIRAKO mice com-
pared to controls (17.3 ± 8.3 and 2.9 ± 2.3 a-actin-positive cells
per section, respectively; p = 0.04; Figure 4D), indicating that
EIRAKO mice had more complex atherosclerotic lesions. The
area occupied by macrophages tended to be higher in EIRAKO
mice (12,664 ± 6,473 mm2 and 5,724 ± 1,444, respectively;
p = 0.16; Figure 4E).
Atherosclerotic lesions in cross-sections of the aortic sinus
were analyzed at 52 weeks of age. The mean cross-sectional
area was not different in EIRAKO and control mice (389,841 ±
77,547 and 359,791 ± 58,034 mm2, respectively; Figures S2A,
S2B, and S2I; p = 0.8). Similarly, there was no difference in pla-
que area positive for macrophage immunostaining (Figures S2C,
S2D, and S2J) or number of smooth muscle cells identified by
immunostaining (Figures S2E and S2F) in the two groups. Most
of the difference in atherosclerotic lesion area in the aorta
appeared to be in the descending aorta, which may explain
why no difference was seen in the aortic sinus. Subocclusive
plaques in coronary arteries were observed in animals from
both groups (Figures S2G and S2H).
eNOS Regulation
In control mice, intravenous injection of insulin resulted in a
69% ± 13% increase in eNOS Ser1177 phosphorylation in the
Figure 4. Brachiocephalic Artery Lesion
Size and Atherosclerotic Plaques Histology
Lipids were quantitatively extracted from the
brachiocephalic artery, which was then paraffin
embedded and cross-sectioned. Cholesteryl
ester was measured in lipid extracts by mass
spectrometry.
(A) Cholesteryl ester content in the brachioce-
phalic artery at 36 weeks.
(B) Cholesteryl ester content in the brachioce-
phalic artery at 52 weeks.
(C–E) Histological staining and immunohistochem-
istry of brachiocephalic artery cross-sections.
Representative images are shown (left), as are
mean values of quantitative analysis (right). (C)
Masson’s trichrome stain, with collagen staining
blue. (D) MAC-2 immunohistochemistry to visu-
alize plaque area occupied by macrophages. (E)
a-smoothmuscle cell actin immunohistochemistry
to identify vascular smoothmuscle cells. In graphs,
error bars represent standard error of the mean.
See also Figure S2.
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Figures 5A and 5B). By contrast, insulin injection did not
not change eNOS phosphorylation in the aortas of EIRAKO
mice compared to vehicle injection (Figures 5A and 5B). eNOS
phosphorylation was not different in aortas from EIRAKO and
control mice injected with vehicle (Figures 5A and 5B). In lung
aortic endothelial cells isolated from control mice, eNOS phos-
phorylation increased 2-fold after treatment with insulin (Figures
5C and 5D, p = 0.01 for aortic endothelial cells). Insulin treatment
did not increase eNOS phosphorylation in cells from EIRAKO
mice, although phosphorylation state tended to be higher in
the unstimulated condition (68% ± 34% higher in unstimulated
aortic endothelial cells from EIRAKO mice than in unstimulated
cells from control mice, p = 0.11, Figures 5C and 5D). Therefore,Cell Metabolism 11, 379–insulin-stimulated eNOS phosphoryla-
tion is lost in EIRAKO mice, both in iso-
lated endothelial cells and in the aorta
in vivo.
eNOS expression is decreased in aorta
and endothelial cells from VENIRKOmice
(Vicent et al., 2003). In EIRAKO mice,
however, no changes in expression of
eNOS mRNA or protein in the aorta
were observed when compared with their
controls (Figures 5E and 5F). In a proa-
therosclerotic environment, eNOS gene
expression is likely upregulated by
factors other than insulin, such as oxida-
tive stress (Drummond et al., 2000).
Indeed, mRNA expression of the antioxi-
dant enzyme HO-1 (Hmox1) was signifi-
cantly increased in EIRAKO mice (to
165% ± 25% of the level in controls,
p = 0.04), likely reflecting that oxidative
stress in a more proatherosclerotic milieu
is quantitatively more important for its
regulation than insulin signaling. Theexpression of other anti- and pro-oxidant genes, including
Sod1, Cybb (Nox2/gp91phox), Ncf1 (p47phox), and Nox4, was
not changed (data not shown). Also, no change was observed
in aortic endothelin-1 (Edn1) expression (expression in EIRAKO
mice 91% ± 8% of and 109% ± 20% of controls at 12 and
20 weeks, respectively; 20 versus 20 and 9 versus 12 animals,
respectively; p > 0.4).
To study the functional consequences of the changes in eNOS
regulation in EIRAKO mice, we measured vasodilation
stimulated by acetylcholine, most of which is dependent on
endothelium-derived NO. Isolated carotid arteries from EIRAKO
mice had decreased sensitivity to acetylcholine, as the EC50 in
EIRAKO mice was almost twice as high as in controls (44 ±
5.6 and 23 ± 3.8 nM, respectively, Figure 5G, p = 0.008).389, May 5, 2010 ª2010 Elsevier Inc. 383
Figure 5. eNOS Regulation
(A) Insulin 5 mU/g was injected i. v. and the aorta
removed after 5 min. Western blotting was per-
formed on aorta lysate.
(B) Mean values of eNOS Ser1177 phosphoryla-
tion relative to eNOS based on densitometry of
western blots of aorta from six sets of four animals.
(C) Primary cultures of lung and aortic endothelial
cells isolated from an EIRAKOmouse and its litter-
mate control were treated with insulin (100 nM in
lung endothelial cells, 10 nM in aortic endothelial
cells, 5 min). Representative western blots are
shown.
(D) Mean values of eNOS Ser1177 phosphoryla-
tion relative to eNOS expression in aortic endothe-
lial cells from three independent experiments.
(E) eNOS mRNA expression in aorta measured by
real-time PCR, mean results from 11 EIRAKOmice
and 9 controls.
(F) eNOS protein in aorta based on densitometry of
western blots and normalized to actin, mean
results from 11 EIRAKO mice and 8 controls.
(GandH) Thecarotid arterywas isolated,mounted,
and pressurized in a myograph. Graphs show
mean vasodilation using arteries from six control
and six EIRAKOmice. (G) Concentration-response
study using acetylcholine. (H) Concentration-
response study using sodium nitroprusside.
In graphs, error bars represent standard error of
the mean.
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concentration-response studies with sodium nitroprusside,
showed that arteries from EIRAKOmice were more NO sensitive
(with an EC50 of 20 ± 2.5 and 39 ± 8.5 nM in EIRAKO and control
mice, respectively, Figure 5H, p = 0.04). These experiments
establish that NO-mediated vasodilation is impaired in EIRAKO
mice compared to controls but indicate that vascular smooth
muscle cell sensitivity to NO is increased, perhaps as a compen-
satory mechanism.
Leukocyte-Endothelial Cell Interaction In Vivo
Decreased eNOS activity plays a major role in the development
of atherosclerosis, in part by decreasing the interaction of mono-
cytes and other leukocytes with endothelium. We therefore
evaluated leukocyte interaction with endothelium in vivo, using
intravital microscopy of the mesenteric circulation after labeling
of leukocytes with a fluorescent dye. In 12-week-old EIRAKO
animals, the number of rolling leukocytes increased by 1.8-fold
compared to controls (26.8 ± 2.9 and 48.7 ± 2.3 rolling leuko-384 Cell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc.cytes per 100 mm in EIRAKO and
controls, respectively, p = 0.004,
Figure 6A). The number of firmly adhering
leukocytes increased by 4.1-fold (1.5 ±
0.3 and 6.2 ± 0.9 adhering leukocytes
per 100 mm, respectively, p < 0.001,
Figure 6B).
We have previously shown an increase
in leukocyte rolling and adherence in
apoE null compared to wild-type mice
while fed a regular chow diet, using thesame intravital preparation as in the current paper (Scalia
et al., 2001). However, rolling and adhesion were not different
between EIRAKO controls and wild-type mice (Figures 6A and
6B), likely because mice used in the previous study were up
to twice as old (Scalia et al., 2001). The apoE null phenotype,
however, could modify the effects of endothelial insulin receptor
knockout on leukocyte-endothelium interaction in EIRAKO
mice. Therefore, we performed experiments in VENIRKO
animals and their controls, both of which are wild-type for
apoE. Leukocyte rolling was increased by 1.8-fold in VENIRKO
mice compared with their littermate controls (57.5 ± 6.9 and
31.3 ± 7.5 rolling leukocytes per 100 mm vessel length, respec-
tively; Figure 6C, p = 0.03). As in EIRAKO mice, leukocyte
adhesion was increased dramatically in VENIRKO mice, by
7.3-fold compared with their controls (3.6 ± 0.4 and 0.5 ± 0.3
adhering leukocytes per 100 mm, respectively; Figure 6D,
p = 0.001). Thus, increased leukocyte-endothelial cell interac-
tion resulting from a loss of insulin signaling occurs in the
abscence of hypercholesterolemia.
Figure 6. Leukocyte-Endothelial Cell Inter-
action In Vivo
(A–D) Circulating leukocytes were fluorescently
labeled by i.v. injection of rhodamine and visual-
ized in peri-intestinal, postcapillary venules by
intravital microscopy. Mean numbers of rolling or
firmly adhering leukocytes in three to four animals
are shown. (A) Leukocyte rolling in EIRAKO mice
and controls. (B) Leukocyte adhesion in EIRAKO
mice. (C) Leukocyte rolling in VENIRKO mice and
controls, both wild-type for apoE. (D) Leukocyte
adhesion in VENIRKO mice and controls.
(E) Western blotting of lysate of PBMCs.
(F) Adhesion in vivo of transferred mononuclear
cells. PBMCswere freshly isolated from one donor
animal, labeled with rhodamine ex vivo, and in-
jected i.v. in a single recipient animal. Mean
numbers of firmly adhering PBMCs, with geno-
types of donor and recipient animals indicated,
are shown (n = 3–5).
(G–I) Bone marrow transplantation in apoE
knockout mice, which were lethally irradiated
and recieved a graft of bone marrow cells from
EIRAKO or control mice. An atherogenic
‘‘Western’’ diet was started the day after trans-
plantation. (G) Western blotting of PBMC lysate 8
weeks after transplantation. (H) Mean values for
IRb protein based on densitometry of western
blots of PBMC from three mice in each group of
apoE knockout mice with EIRAKO or control
bone marrow replacement. See also Figure S3.
(I) Mean values for atherosclerotic lesion area in
the aorta in 11 recipients of EIRAKO mice bone
marrow and 11 recipients of control bone marrow
8 weeks after bone marrow transplantation.
Abbreviations: E, endothelial insulin receptor and apoE knockout (EIRAKO) mice; V, vascular endothelial receptor knockout (VENIRKO) mice; PBMC, peripheral
blood mononuclear cells.
In graphs, error bars represent standard error of the mean.
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Transplantation
When it was first characterized, the Tie2-Cre transgene used in
the creation of EIRAKO mice did not result in Cre-mediated
recombination in embryonic hematopoietic cells (Kisanuki
et al., 2001). However, a recent study showed that Tie2 was
expressed in 20% of human blood monocytes (Murdoch et al.,
2007). We therefore measured insulin receptor expression in
peripheral blood mononuclear cells (PBMCs) from EIRAKO
mice and found that IRb protein was reduced by 68% compared
with controls (Figure 6E). IRb was also reduced in thioglycollate-
induced peritoneal macrophages (Figure S3) and in bone
marrow (data not shown). To determine whether the large
increase in firmly adhering leukocytes in EIRAKO mice was
due to decreased insulin receptor expression in mononuclear
cells, PBMC were isolated from wild-type mice, from EIRAKO
mice, or from their littermate controls and subsequently injected
intravenously into wild-type recipients after being labeled ex vivo
with a fluorescent dye. The adherence of PBMC to wild-type
endothelium was not different whether the donor PBMCs were
from wild-type mice, EIRAKO mice, or their littermate controls
(0.60 ± 0.25, 0.83 ± 0.17, or 0.75 ± 0.32 adhering leukocytes
per 100 mm, respectively, Figure 6F). Each of these rates of
adherence was not different from the adherence of PBMC fromCwild-type mice when injected into control mice (0.75 ± 0.48
adhering leukocytes per 100 mm, Figure 6F). These data demon-
strate that PBMC from both EIRAKO mice and their controls
were functionally normal with respect to their adherence to
endothelial cells. In contrast, when PBMC were isolated from
wild-type mice and injected into EIRAKO recipients, the number
of adhering donor cells wasmore than 4-fold higher than in any of
the other transfer experiments (3.7 ± 0.1 adhering PBMC per
100 mm, Figure 6F, p < 0.001). Therefore, the abnormally high
leukocyte-endothelial cell adhesion in EIRAKO mice is caused
by a functional abnormality in the endothelium rather than in
leukocytes.
Once resident in the vascular wall, leukocytes with reduced
insulin receptor expression could contribute to plaque develop-
ment differently than leukocytes with normal expression of
insulin receptor protein. We therefore studied whether bone
marrow-derived cells from EIRAKO mice would cause different
atherosclerosis progression than control bone marrow cells.
apoE null mice were lethally irradiated and received bone
marrow grafts from either EIRAKO mice or littermate controls.
Chimerism after bone marrow replacement was evident by a
reduction of IRb protein by 79% ± 3% in PBMC isolated from
apoE null mice transplanted with EIRAKO bone marrow grafts
compared to recipients of control bone marrow (Figures 6Gell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc. 385
Figure 7. VCAM-1 Regulation
(A) Western blotting of whole-cell lysate from lung endothelial cells isolated
from one EIRAKO mouse and one control, with each sample loaded as four
replicates.
(B) Mean values for VCAM-1 protein based on densitometry of western blots of
lung endothelial cell lysate from four pairs of EIRAKO mice and controls.
(C) Western blotting of whole-cell lysate from MS1 endothelial cells.
(D) Mean values for ICAM-1 and VCAM-1 protein based on densitometry of
western blots from three independent experiments in MS1 endothelial cells.
(E and F) Leukocyte rolling on and firm adhesion to endothelium of peri-intes-
tinal, postcapillary venules visualized by intravital microscopy after fluorescent
labeling by i.v. injection of rhodamine. Measurements were repeated 60 min
after i.v. injection of a VCAM-1-blocking antibody. Mean values from four pairs
of animals 20–23 weeks of age are shown. (E) Leukocyte rolling before and
after VCAM-1 injection. (F) Leukocyte adhesion before and after VCAM-1
injection.
In graphs, error bars represent standard error of the mean.
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sion comparable to the level seen in EIRAKOmice, aortic athero-
sclerotic lesion area 8 weeks after transplantation was no
different in recipients of EIRAKO bone marrow than in recipients
of control bone marrow (Figure 6I).
Regulation of VCAM-1
Endothelial cells affect leukocyte adhesion, and to some extent
leukocyte rolling, by expression levels of ICAM-1 and VCAM-1.
In lung endothelial cells from EIRAKO mice, VCAM-1 protein
expression was 199% ± 29% of the level seen in cells isolated386 Cell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc.from control mice (Figures 7A and 7B, p = 0.01), whereas
ICAM-1 protein expression was no different (Figure 7A). This
suggested that insulin might negatively regulate VCAM-1.
When MS1 mouse endothelial cells were treated with 10 nM
insulin, VCAM-1 protein expression was reduced by 22% ±
8.3% after 24 hr (p = 0.06), 46% ± 7% after 48 hr (p = 0.01),
and by 57% ± 2% after 72 hr (p = 0.01) compared with cultures
grown under identical conditions for the same duration without
insulin (Figures 7C and 7D). No changes were seen either 4 or
8 hr after insulin treatment (data not shown).
To demonstrate that increased expression of VCAM-1 was the
cause of increased leukocyte-endothelial cell interaction in vivo,
we used a VCAM-1 antibody with documented ability to block
leukocyte adhesion to endothelial cells. Leukocyte rolling and
adhesion was monitored by intravital microscopy before and
60 min after intravenous injection of the antibody. This treatment
had no significant effect on leukocyte rolling in EIRAKO or control
mice (Figure 7E, p > 0.2). However, the VCAM-1 antibody
decreased leukocyte adhesion in EIRAKO mice by 72.6% ±
1.0%, to below control levels (Figure 7F, p = 0.01). These results
indicate that VCAM-1 upregulation in EIRAKO mice contributes
significantly to the increased leukocyte-endothelial adhesion
observed in these animals.
DISCUSSION
The current study provides definitive evidence that a loss of
insulin signaling in the vascular endothelium without changes
in systemic metabolism promotes early events in atherogenesis
and accelerates the progression of advanced atherosclerotic
disease. These outcomes support the hypothesis previously
examined by us (Jiang et al., 1999) and others (Steinberg et al.,
1996), proposing that in patients with obesity or type 2 diabetes,
insulin resistance in endothelial cells may contribute to increased
risk for development of cardiovascular disease.
Our results show that systemic insulin action in EIRAKO mice
is no different than in control mice. Thus, endothelial insulin
resistance did not cause changes in whole-body glucose toler-
ance, circulating insulin concentrations, or insulin sensitivity in
EIRAKO mice compared to controls. This is consistent with
what has previously been reported for VENIRKO mice (Vicent
et al., 2003) and with findings in transgenic mice with a mutant
insulin receptor targeted to endothelium (Duncan et al., 2008).
Furthermore, the similarity in cholesterol and triglyceride content
in lipoproteins between EIRAKO mice and their controls shows
that insulin signaling in endothelial cells does not significantly
alter regulation of lipoprotein metabolism in the liver or adipose
tissue. This lack of differences in systemic insulin sensitivity or
lipoprotein profile between control and EIRAKOmice is essential
in order for us to conclude that the accelerated atherosclerosis in
EIRAKO mice is a direct result of the loss of insulin action on the
endothelium.
Leukocyte rolling on and adhesion to endothelial cells in vivo
were increased in both EIRAKO mice, which are apoE null,
and VENIRKO mice, which are apoE wild-type. These findings
correspond with results showing upregulation of VCAM-1
expression in endothelial cells isolated from EIRAKO mice, and
decreased VCAM-1 protein expression in endothelial cells
treated with insulin. The functional significance of this finding
Cell Metabolism
Endothelial Insulin Resistance and Atherosclerosiswas demonstrated by experiments in vivo showing that a VCAM-
1-blocking antibody reduced leukocyte-endothelial cell adhe-
sion in EIRAKO mice to below control levels. Epidemiological
evidence supports that upregulation of VCAM-1 in association
with insulin resistance is clinically important, because in patients
with type 2 diabetes, soluble VCAM-1 concentrations are
independently associated with cardiovascular mortality (Jager
et al., 2000). However, previously published mechanistic studies
on the effect of insulin on the expression of factors that promote
adhesion have been contradictory. Several studies, among them
work by De Catarina et al. (Madonna et al., 2004), have shown
that insulin can increase the expression of ICAM-1 and VCAM-1
in endothelial cells, although other studies have shown that
insulin inhibits expression of ICAM-1 (Aljada et al., 2000) and
P-selectin (Booth et al., 2001). We are not aware of previously
published evidence demonstrating regulation of VCAM-1 by
insulin in vivo.
In the current study, NO-mediated vasodilator function was
impaired in EIRAKO mice, and loss of insulin-stimulated phos-
phorylation of Akt and eNOS was clearly demonstrated in the
aorta in vivo and in isolated endothelial cells. NO synthesized
by eNOS decreases both leukocyte rolling and adhesion (Lefer
et al., 1999), and NO has been shown to inhibit expression of
VCAM-1 and other factors promoting leukocyte adhesion
through deactivation of NF-kB (De Caterina et al., 1995; Khan
et al., 1996). Therefore, decreased endothelium-derived NO
could result in increased expression of adhesion molecules or
promote atherosclerotic plaque development and complexity
through other mechanisms. For example, impaired NO produc-
tion could increase the number of intraplaque vascular smooth
muscle cells, as shown by our data from brachial artery immuno-
histochemistry, because NO inhibits vascular smooth muscle
cell migration (Sarkar et al., 1996). However, NO production
could not account for insulin-stimulated downregulation of
VCAM-1 in our cell culture studies, as L-NAME was unable to
block these effects of insulin. Therefore, it is likely that the regu-
lation of VCAM-1 by insulin is mediated by another mechanism,
perhaps through the nuclear factor forkhead box O1 (FoxO1/
FKHR). Transcriptional activity of FoxO1 is suppressed by insulin
(Nakae et al., 1999; Tang et al., 1999), and FoxO1 activation
upregulates VCAM-1 expression (Abid et al., 2006). Such mech-
anisms may be similar to or separate from the proinflammatory
and proatherosclerotic changes observed in whole-body
Akt1–/– mice (Fernandez-Hernando et al., 2007). These questions
are currently being investigated in our laboratory.
We observed a dramatic increase in mononuclear cell adhe-
sion when mononuclear cells from wild-type mice were injected
into EIRAKO mice. In contrast, no abnormality of mononuclear
cell adhesion to endothelial cells was observed when mononu-
clear cells from EIRAKO mice were injected into control
littermates or wild-type mice. These data show that increased
leukocyte-endothelial cell interaction in EIRAKO mice is caused
by endothelial cell dysfunction rather than changes in monocyte
function. Similarly, replacement of bone marrow in apoE null
mice with bone marrow from EIRAKO mice or their controls
showed that insulin receptor downregulation in bone marrow-
derived cells was not sufficient to accelerate atherosclerosis.
We therefore conclude that the vascular inflammation and accel-
erated atherosclerosis observed in EIRAKOmice is a result of theCloss of insulin signaling in endothelial cells, with no significant
contribution from the downregulation of insulin signaling in
leukocytes.
A previous study has shown that the loss of insulin receptors in
macrophages or leukocytes may decrease atherosclerosis in
apoE null mice (Baumgartl et al., 2006). Furthermore, replacing
the bone marrow in apoE null mice with transplants from insulin
receptor substrate-2 (IRS-2)/apoE double knockout mice
decreased atherosclerosis even though IRS-2/apoE double
knockout mice had increased atherosclerosis compared to
apoE null controls (Baumgartl et al., 2006; Gonzalez-Navarro
et al., 2008). Another study showed that transplantation of
bone marrow from insulin receptor null mice to lethally irradiated
LDL receptor null mice had no effect after 8 weeks of an athero-
genic diet and demonstrated a modest increase after 12 weeks
(Han et al., 2006), as well as increased apoptosis of macro-
phages and an increased rate of necrotic core formation in
atherosclerotic plaques. Therefore, even though decreased
expression of insulin receptor in mononuclear cells in EIRAKO
mice did not appear to affect increased leukocyte-endothelial
interaction or atherosclerotic development, complete loss of
insulin signaling in leukocytes, or loss of insulin action in certain
subsets of bone-marrow derived cells, may decrease the
progression of atherosclerosis while promoting necrotic core
formation in more advanced plaques.
In vascular tissue from obese rats and patients with diabetes,
the major insulin signaling pathway represented by PI3K and Akt
is affected selectively by insulin resistance, whereas the pathway
represented by mitogen-activated protein kinase (MAPK) is
intact (Jiang et al., 1999). We have therefore proposed that in
the normal, insulin-sensitive state, insulin action on the endothe-
lium is mainly mediating antiatherogenic effects by activating the
PI3K/Akt pathway (Jiang et al., 1999). However, in the insulin
resistant state, often associated with hyperinsulinemia, proa-
therogenic insulin action on endothelium may be mediated by
MAPK pathways (Rask-Madsen and King, 2007). By using a
mouse model with a null mutation of the insulin receptor gene
in endothelial cells, our study may underestimate the contribu-
tion of selective insulin resistance in the endothelium in disease
states because potential proatherosclerotic insulin signaling
mediated by MAPK is lost in the mouse model, while it may be
functional in human disease. Future studies will be needed to
determine whether enhancement of the insulin receptor
substrate/PI3K/Akt signaling pathway in endothelium can delay
atherosclerosis development.
In summary, we have demonstrated that insulin action on the
endothelium is mainly antiatherogenic and that loss of insulin
signaling in endothelial cells promotes initiation of atheroscle-
rosis and its progression, and increases the complexity of
advanced atherosclerotic lesions. The findings further indicate
that insulin plays a quantitatively prominent role in maintaining
normal endothelial function, and that endothelial insulin resis-
tance may accelerate atherosclerosis by causing impaired
activation of eNOS, increased endothelial expression of
VCAM-1, and increased leukocyte interaction with endothelial
cells. These results provide the rationale for identifying interven-
tions that can decrease the risk of atherosclerotic disease in
patients with insulin resistance or diabetes by alleviating insulin
resistance in the endothelium.ell Metabolism 11, 379–389, May 5, 2010 ª2010 Elsevier Inc. 387
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Additional details of the Experimental Procedures are included in the Supple-
mental Information.
Animals
VENIRKO mice (Vicent et al., 2003) were cross-bred with apoE null mice using
breeding of Cre-positivemales andCre-negative females.MaleCre+ Insrflox/flox
Apoe–/– (EIRAKO) mice and littermate Cre– Insr flox/flox Apoe–/– (control) mice
were used for experiments. Mice were fed a regular chow diet with 9.0%
(w/w) fat and 0.221 ppm cholesterol. All protocols for animal use and eutha-
nasia were reviewed and approved by the Animal Care Committee of the Joslin
Diabetes Center andwere in accordancewith National Insitutes of Health (NIH)
guidelines.
Cell Culture
Cell culture was obtained from lung tissue or aorta after digestion with collage-
nase. Endothelial cells were isolated during the first two passages with the use
of magnetic beads complexed to ICAM-2 antibody as described previously
(Hartwell et al., 1998). Aortic smooth muscle cells were obtained as the
ICAM-2-negative fraction after immunoselection of cells cultured from aortic
digest. MS1 endothelial cells were purchased from the American Type Culture
Collection (ATCC, Manassas, VA) and cultured in DMEM containing 5% FBS.
Carotid Vasodilation
Concentration-response studies of vasodilation stimulated by acetylcholine
and sodium nitroprusside were performed as described previously (Atochin
et al., 2007).
Intravital Microscopy and Quantitation of Leukocyte-Endothelial
Cell Interaction
Leukocyte-endothelial cell interaction was observed in postcapillary venules
of the peri-intestinal microcirculation as described (Ouedraogo et al., 2007).
Analysis of Atherosclerotic Plaques in the Aorta,
the Brachiocephalic Artery, and the Aortic Sinus
The whole aorta, from just distal to the aortic sinus to the iliac bifurcation, was
stained with Sudan IV. The stained aortas were placed between two glass
slides and photographed under polarized light through a dissection micro-
scope. Lipids were extracted from the brachiocephalic artery and analyzed
for cholesteryl ester abundance by mass spectrometry as previously
described (Kuo et al., 2008). Cross-sections of paraffin-embedded brachioce-
phalic artery and cryosections of the aortic sinus were stained as described
previously (Kuo et al., 2008).
Statistical Analysis
Comparisons were made using paired or unpaired t test, as appropriate, with
p < 0.05 considered statistically significant. In text and graphs, data are
presented as the mean ± standard error of the mean.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
at doi:10.1016/j.cmet.2010.03.013.
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